Page 64 - Sohini Das

No plans to exit business, clarify Metropolis Healthcare promoters

Metropolis Healthcare is continuously exploring various strategic options and investment

Corbevax gets approval as heterogenous vax, but isn't listed on CoWin

Company had issued a press release on June 4 where it said DCGI has approved Corbevax as a heterologous Covid booster dose to individuals aged 18 and above after 6 months of primary vaccination

Hundreds of millions of Covid vaccines in India to expire in September

Covaxin has a shelf life of 12 months, while Covishield, the vaccine that accounted for nearly 80% of India's vaccinations, has a shelf life of nine months

Gene therapy to cure leukemia at one-tenth global costs in the works

ImmunoACT, backed by Laurus Labs is testing their cancer product

Mumbai amps up hospital capacity and stocks medicines as Covid cases rise

Occupancy has more than doubled over the last week

Covid-19 testing drops even as daily cases rise to three-month high

Testing volumes have not grown much nationally, though individual states show some improvement

India's Serum Institute to make Novavax's Covid vaccine for US market

The company has indicated in the first quarter earnings call that it has reached a major milestone in its pathway to an emergency use authorisation from the US Food and Drugs Administration

Mumbai boosts hospital capacity as Covid cases rise, bed occupancy doubles

Around 10 out of every 1,000 beds are already occupied by Covid-19 patients, up from 4 a week ago

Covid-19 pandemic: Maharashtra, Kerala on high alert as cases spike

On Tuesday, Maharashtra recorded 1,881 new Covid cases, 81 per cent more than the previous day and highest since February 18

Paraguay cancels orders for one million doses of Covaxin, say sources

Media reports cite quality issues; sources say Bharat Biotech had stopped production and exports in April, any pending orders stand cancelled

Price is the key growth driver of Indian pharma market, shows AWACS data

Market set to grow by 2.5-5% in calendar 2022. could even hit 5% due to a strong seasonal sales such as anti-infectives, and impact of NLEM drugs price hike

Boehringer Ingelheim obtains ad-interim injunctions on 4 Indian pharma cos

The firms had launched generic versions of Boehringer's patent-protected drug Linagliptin, which is marketed under the brand name Trajenta

Shot in the arm for boosters: Demand jumps 20% as Covid cases spike

On Saturday, the daily vaccination in the state touched 100,000, said Sachin Desai, state immunisation officer

Covid-19 vaccine: SII to test Novavax for Omicron variant strain

The Pune-based company has also got a nod from the Indian drug regulator's office to manufacture trial batches of this vaccine for the purpose of testing, sources indicated.

Biological E's Corbevax gets DCGI nod as a heterologous Covid booster dose

The Hyderabad-based company claimed that the booster dose of Corbevax increased the neutralising antibody titers in the Covishield and Covaxin groups significantly when compared to placebo

Covid-19 cases at three-month high; up vigil, says health ministry

Centre writes to Maharashtra, Karnataka, Kerala, Telangana & TN

WhatsApp India, GoI join hands to leverage Chatbot for non-Covid use-cases

These collaborations happen despite several run ins between the two on regulatory issues

India mulls study on long-term impact of Covid-19 vaccines on children

Children have not reported very serious disease cases, apart from those who had serious co-morbidities like cancer, other underlying ailments

Maharashtra CM warns of curbs as Covid case positivity spikes in Mumbai

Meanwhile, the Mumbai civic body has also asked the jumbo Covid centres to be fully staffed and be on a standby

Renew focus on communicable diseases, not Covid-19 pandemic: Experts

Public health expert Anish T S says during the pandemic, reported cases of tuberculosis and typhoid were fewer